MedPath

Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome

Phase 2
Completed
Conditions
Dysfunctional Uterine Bleeding
Interventions
Drug: Kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine
Drug: Gong Xue Ning capsules
Registration Number
NCT04528108
Lead Sponsor
Children's Hospital of Fudan University
Brief Summary

The purpose of this study is to conduct a randomized, single blind, controlled intervention trial to observe the therapeutic effect of kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine periodic therapy for dysfunctional uterine bleeding based on objective Chinese and western medicine evaluation standard.

Detailed Description

Dysfunctional uterine bleeding during adolescence is the most common menstrual disorders during adolescence, and the age of children suffering from it tended to be lower. It's urgent to explore effective ways to alleviate the pain caused by dysfunctional uterine bleeding.

In our research, 160 children are randomly divided into a Chinese medication periodic therapy group (80 cases) and a Gong Xue Ning control group (80 cases). Paticipants in Chinese medication periodic therapy group are treated with kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine for 3 months, whereas the Gong Xue Ning control group received Gong Xue Ning capsules for 3 months. We compare the effect of the two therapies about hemostasis and menstruation regulation, and the change of the thickness of endometrium, sex hormones, Kisspeptin, and PAI-1 in blood before and after the treatment, in order to make clear the efficacy and the mechanism of the Chinese medicine periodic therapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • satisfy the diagnostic criteria in the textbook<Obstetrics and Gynecology> with dysfunctional uterine bleeding
  • age between 10-18 years
  • course of the disease is 2 months or more.
Exclusion Criteria
  • have uterine bleeding on account of systemic diseases or organic diseases in reproductive system, such as blood diseases, thyroid diseases, hepatic diseases, etc.
  • HB<80g/L
  • have mental disorders
  • allergic to many kinds of drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ZYZQ GroupKidney-tonifying and tune up Chong-Ren hemostasis Chinese medicineZYZQ group is the experimental group which is treated with kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine for 3 months.
GXN GroupGong Xue Ning capsulesGXN group is the active Comparator group which is treated with Gong Xue Ning capsules for 3 months
Primary Outcome Measures
NameTimeMethod
Restoration of menstruation cycle(binomial)the end of the third months

Restoration of menstruation cycle is a binomial variable. Through clinical follow-up and menstrual diary, we record participants' menstrual period at month 3 of the treatment to confirm the restoration of menstruation, and we regard the menstrual cycle that is within 25-35 days as a normal cycle. Then normal cycles are defined as 1, and the rest are defined as 0.

Secondary Outcome Measures
NameTimeMethod
Menstrual blood volumeduring procedure (about 3 months)

Menstrual blood volume is a repeated measurement variable. We give every participant a pictorial blood loss assessment chart (PBAC) to measure the menstrual blood volume. They fill in the chart every day during menstrual period according to the degree to which each item of sanitary protection was soiled with blood, thus we can calculate a score and speculate the menstrual blood volume based on that.

Menstrual hemostatic timeduring procedure (about 3 months)

We give every patient a menstrual diary to record the length of menstrual bleeding every month in order to confirm the hemostatic time.

Trial Locations

Locations (1)

Children's Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath